Secondary Advisor: 2018 – 2019

Robert Laprairie
Dr. Robert Laprairie: Assistant Professor and GSK-CIHR Research Chair in Drug Discovery and Development.

Dr. Laprairie will serve as the chapter secondary advisor, in order to make smooth transition when he will become the primary advisor next year. The chapter executive members are thrilled to have Dr. Laprairie on board.

Bio: He received his BSc. Hon. Biochemistry from University of Saskatchewan (2010), and MSc. Pharmacology & Neuroscience (2012) as well as  PhD. Pharmacology (2016) from Dalhousie University, Nova Scotia, Canada. He completed a  Postdoctoral fellowship (2017) at The Scripps Research Institute, Florida, USA. Dr. Laprairie is a member of the Drug Discovery and Development Research Group and the Cannabinoid Research Initiative of Saskatchewan (CRIS). He is a member of the Canadian Society for Pharmacology and Therapeutics (CSPT), the Canadian Consortium for the Investigators of Cannabinoids (CCIC), the American Society for Pharmacology and Experimental Therapeutics (ASPET), and the International Cannabinoids Research Society (ICRS).  

Create your website at
Get started
%d bloggers like this: